Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
The impact of routine utilization of two assessment scales on management of antipsychotic-induced side effects
Source of recordUK Trials
ISRCTNISRCTN88391730
Date ISRCTN assigned30/09/2005
Local reference number(s)N0146155662
Public titleThe impact of routine utilization of two assessment scales on management of antipsychotic-induced side effects
Scientific title
AcronymN/A
Disease/condition/study domainMental and Behavioural Disorders: Psychosis
Study hypothesisTo identify the effects of introduction of two assessment scales to regularly appraise antipsychotic-induced side effects in forensic psychiatric patients on management of these side effects and patients' clinical outcome
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria30 (study) and 30 (control) patients in the Forensic Mental Health Unit, Homerton
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/10/2003
Anticipated end date30/04/2004
Status of trialCompleted
Target number of participants30 (study) and 30 (control) patients
InterventionsRandomised controlled trial
Primary outcome measure(s)Changes/differences in the scales ratings at the baseline and the end-assessment within the control and study group and between groups. Differences in the general mental health rating at the beginning and the end-assessment between the control and the study groups. Associations between side effects assessment and the general mental health status.
Secondary outcome measure(s)See Primary outcome measures
Sources of fundingEast London and The City Mental Health NHS Trust
Not available
Sponsor nameRecord Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameMr Albert Ngan
Contact detailsHomerton Hospital NHS Trust
Homerton University Hospital
Homerton Row

London
United Kingdom
E9 6SR
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN88391730
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central